According to FutureWise analysis, the market for Adult Vaccines was estimated to be US$ 17.92 billion in 2023 and is expected to reach US$ 31.54 billion by 2031 at a CAGR of 7.32% over the forecast period of 2025-2033.
Vaccination represents a biological intervention developed to confer active acquired immunity against specific infections or malignant diseases. This process involves the introduction of a weakened, inactivated, or partial form of the pathogen—such as a virus or bacterium—into the body. Such exposure activates the immune response, leading to the production of antibodies and memory cells that can recognize and combat actual pathogens upon future exposure. Vaccines are widely acknowledged as the most effective public health measure, playing a crucial role in the prevention and control of numerous infectious diseases, several of which have historically been the deadliest and most pervasive.
Vaccines may be classified as prophylactic, aimed at preventing future infections by pathogens, or therapeutic, designed to address diseases that have already manifested, such as cancer. Some vaccines provide complete prevention, granting full sterilizing immunity. The act of giving vaccines is commonly known as vaccination. Notable accomplishments in disease eradication, including smallpox, as well as the containment of diseases such as tetanus, polio, and measles, have been significantly enabled by vaccines. The COVID-19 pandemic serves as a recent illustration of the efficacy of vaccines and the vital impact of vaccination initiatives in mitigating the crisis.
FutureWise Market Research has published a report that provides an insightful analysis of Adult Vaccines Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=11132&type=requestsample
Adult Vaccines Market Segmentation:
By Type
• Preventive Vaccine
• Therapeutic Vaccine

By Disease
• Measles
• Mumps
• Varicella
• DPT
• Hepatitis
• Influenza
• Typhoid
• Meningococcal
• Pneumococcal
• Zoster Shingles
• Rubella

By Technology
• Non-Live Attenuated Vaccines
• Inactivated Viral/Bacterial Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Conjugate Vaccines

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Adult Vaccines Market:
• AstraZeneca
• Bharat Biotech
• Dynavax Technologies Corporation
• GlaxoSmithKline
• Johnson & Johnson
• Merck and Co
• Novartis
• Pfizer
• Sanofi Pasteur
• Serum Institute of India
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=11132&license=multi

**Objectives of this Study: **
1. To provide a comprehensive analysis of the Adult Vaccines Market By Product Type, By Application and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com